Seres Therapeutics, Inc.(NasdaqGS:MCRB) dropped from S&P Biotechnology Select Industry Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.949 USD | +3.16% | -1.67% | -32.21% |
May. 09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
May. 09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.21% | 139M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Seres Therapeutics, Inc.(NasdaqGS: MCRB) dropped from S&P Biotechnology Select Industry Index